|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 478.16 USD | -1.42% |
|
-5.11% | -1.87% |
| 03-05 | United Therapeutics Insider Sold Shares Worth $4,744,467, According to a Recent SEC Filing | MT |
| 03-05 | United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 535.1 | 535.1 | 517.13 |
| Spread/Res. | -10.64% | -10.64% | -7.54% |
| Spread/Supp. | +1.00% | +1.00% | +28.94% |
| Support | 473.42 | 473.42 | 370.83 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition